News
BASEL, Switzerland I July 02, 2025 I BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of ...
A new study by University of Bath scientists has highlighted two new potential families of drug molecules that could open the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback